Jessica N Redgrave1, Lucy Moore2, Tosin Oyekunle2, Maryam Ebrahim2, Konstantinos Falidas2, Nicola Snowdon2, Ali Ali3, Arshad Majid4. 1. Sheffield Institute of Translational Neuroscience, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom. Electronic address: Jessica.redgrave@sth.nhs.uk. 2. Centre for Health and Social Care Research, Sheffield Hallam University, Sheffield, United Kingdom. 3. Sheffield Institute of Translational Neuroscience, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom. 4. Sheffield Institute of Translational Neuroscience, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom. Electronic address: arshad.majid@sheffield.ac.uk.
Abstract
BACKGROUND: Invasive vagus nerve stimulation (VNS) has the potential to enhance the effects of physiotherapy for upper limb motor recovery after stroke. Noninvasive, transcutaneous auricular branch VNS (taVNS) may have similar benefits, but this has not been evaluated in stroke recovery. We sought to determine the feasibility of taVNS delivered alongside upper limb repetitive task-specific practice after stroke and its effects on a range of outcome measures evaluating limb function. MATERIALS AND METHODS: Thirteen participants at more than 3 months postischemic stroke with residual upper limb dysfunction were recruited from the community of Sheffield, United Kingdom (October-December 2016). Participants underwent 18 × 1-hour sessions over 6 weeks in which they made 30-50 repetitions of 8-10 arm movements concurrently with taVNS (NEMOS; Cerbomed, Erlangen, Germany, 25 Hz, .1-millisecond pulse width) at maximum tolerated intensity (mA). An electrocardiogram and rehabilitation outcome scores were obtained at each visit. Qualitative interviews determined the acceptability of taVNS to participants. RESULTS: Median time after stroke was 1.16 years, and baseline median/interquartile range upper limb Fugl-Meyer (UFM) score was 63 (54.5-99.5). Participants attended 92% of the planned treatment sessions. Three participants reported side effects, mainly fatigue, but all performed mean of more than 300 arm repetitions per session with no serious adverse events. There was a significant change in the UFM score with a mean increase per participant of 17.1 points (standard deviation 7.8). CONCLUSION: taVNS is feasible and well-tolerated alongside upper limb repetitive movements in poststroke rehabilitation. The motor improvements observed justify a phase 2 trial in patients with residual arm weakness.
BACKGROUND: Invasive vagus nerve stimulation (VNS) has the potential to enhance the effects of physiotherapy for upper limb motor recovery after stroke. Noninvasive, transcutaneous auricular branch VNS (taVNS) may have similar benefits, but this has not been evaluated in stroke recovery. We sought to determine the feasibility of taVNS delivered alongside upper limb repetitive task-specific practice after stroke and its effects on a range of outcome measures evaluating limb function. MATERIALS AND METHODS: Thirteen participants at more than 3 months postischemic stroke with residual upper limb dysfunction were recruited from the community of Sheffield, United Kingdom (October-December 2016). Participants underwent 18 × 1-hour sessions over 6 weeks in which they made 30-50 repetitions of 8-10 arm movements concurrently with taVNS (NEMOS; Cerbomed, Erlangen, Germany, 25 Hz, .1-millisecond pulse width) at maximum tolerated intensity (mA). An electrocardiogram and rehabilitation outcome scores were obtained at each visit. Qualitative interviews determined the acceptability of taVNS to participants. RESULTS: Median time after stroke was 1.16 years, and baseline median/interquartile range upper limb Fugl-Meyer (UFM) score was 63 (54.5-99.5). Participants attended 92% of the planned treatment sessions. Three participants reported side effects, mainly fatigue, but all performed mean of more than 300 arm repetitions per session with no serious adverse events. There was a significant change in the UFM score with a mean increase per participant of 17.1 points (standard deviation 7.8). CONCLUSION: taVNS is feasible and well-tolerated alongside upper limb repetitive movements in poststroke rehabilitation. The motor improvements observed justify a phase 2 trial in patients with residual arm weakness.
Authors: Roberta Sclocco; Ronald G Garcia; Norman W Kettner; Harrison P Fisher; Kylie Isenburg; Maya Makarovsky; Jessica A Stowell; Jill Goldstein; Riccardo Barbieri; Vitaly Napadow Journal: Brain Stimul Date: 2020-03-27 Impact factor: 8.955
Authors: Daniel N Cook; Sean Thompson; Sasha Stomberg-Firestein; Marom Bikson; Mark S George; Dorothea D Jenkins; Bashar W Badran Journal: Brain Stimul Date: 2020-02-27 Impact factor: 8.955
Authors: Bashar W Badran; Dorothea D Jenkins; Daniel Cook; Sean Thompson; Morgan Dancy; William H DeVries; Georgia Mappin; Philipp Summers; Marom Bikson; Mark S George Journal: Front Hum Neurosci Date: 2020-03-18 Impact factor: 3.169
Authors: Georgia H O'Leary; Dorothea D Jenkins; Patricia Coker-Bolt; Mark S George; Steve Kautz; Marom Bikson; Bernadette T Gillick; Bashar W Badran Journal: Prog Brain Res Date: 2021-02-23 Impact factor: 2.624
Authors: Meghan E Addorisio; Gavin H Imperato; Kevin J Tracey; Sangeeta S Chavan; Alex F de Vos; Steve Forti; Richard S Goldstein; Valentin A Pavlov; Tom van der Poll; Huan Yang; Betty Diamond Journal: Bioelectron Med Date: 2019-04-17
Authors: Anne van der Meij; Marianne A A van Walderveen; Nyika D Kruyt; Erik W van Zwet; Eric J Liebler; Michel D Ferrari; Marieke J H Wermer Journal: Trials Date: 2020-10-26 Impact factor: 2.279